CEA-targeted ISAC elicits complete responses in mice and is well-tolerated in NHPs PD-L1 ISAC directly activates and reprograms PD-L1-expressing myeloid cells in the TME to drive complete responses ...

Shahrzad Zamani will graduate as a doctor of osteopathic medicine next month from the Philadelphia College of Medicine’s ...

The annual Lung Cancer Action Week (May 5-11, 2025) unites America to stand together against lung cancer.

Part of Lung Association’s Lung Cancer Action Week which urges public to take five actions to help save lives, raise awareness of lung cancer ...

As the luminary ceremony began and candlelit bags glowed in the dark, each carrying the name of a loved one, Zach felt ...

As former NCI Director W. Kimryn Rathmell, MD, PhD, MMHC, embarks on the next stage of her career as CEO of the James Cancer ...

In this week’s edition of InnovationRx, we look at a patent fight over the world’s top-selling drug, breakthroughs from the ...

While breast cancer incidence increased between 2018 and 2022, mortality rates for women ages 20 to 49 declined significantly between 2010 and 2020, according to new research presented April 29 at the ...

The use of an investigational topical BRAF-inhibiting gel appeared to be effective in treating acneiform rash in patients ...

Neoadjuvant PD-1 blockade with dostarlimab enables nonoperative management strategy for large proportion of patients.

Some incredible advancements in cancer research and care are being announced this week in Chicago. The American Association ...

Prior studies have shown that women may absorb cancer therapies differently than men, but this study focused on the fallout ...